130 related articles for article (PubMed ID: 11268894)
1. [Late reversal leprous reaction appearing 18 months after the termination of treatment].
Bourée P; de Brette A; de Carsalade GY
Presse Med; 2001 Mar; 30(8):376. PubMed ID: 11268894
[No Abstract] [Full Text] [Related]
2. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
Naafs B
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120
[No Abstract] [Full Text] [Related]
3. [Polyarthritis and papular eruption revealing leprosy].
Meyer M; Ingen-Housz-Oro S; Ighilahriz O; Wendling J; Gaulier A; Levy-Weil F; Sigal-Grinberg M; Flageul B
Rev Med Interne; 2008 Mar; 29(3):242-5. PubMed ID: 17976874
[TBL] [Abstract][Full Text] [Related]
4. Facial reversal reaction: a dermatological emergency.
Marzano AV; Tosi D; Cusini M; Nunzi E; Massone C; Crosti C
J Dermatol; 2012 Feb; 39(2):203-5. PubMed ID: 21951390
[No Abstract] [Full Text] [Related]
5. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
6. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
Thomas A; Hari L; Nagarajan M; Prabhakar R
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
[TBL] [Abstract][Full Text] [Related]
7. First report of leprosy presenting as acute polyarthritis in the setting of type I downgrading lepra reaction.
Al-Raqum HA; Uppal SS; El Abdalghani RA; Lasheen I
Clin Rheumatol; 2006 Feb; 25(1):101-5. PubMed ID: 16247582
[TBL] [Abstract][Full Text] [Related]
8. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
Armour KS; Scolyer RA; Barnetson RS
Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
[TBL] [Abstract][Full Text] [Related]
9. [Drug resistance of Mycobacterium leprae].
Pattyn SR
Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
[No Abstract] [Full Text] [Related]
10. Borderline lepromatous leprosy in an Italian man.
Massone C; Clapasson A; Nunzi E
Am J Trop Med Hyg; 2013 Feb; 88(2):211. PubMed ID: 23390219
[No Abstract] [Full Text] [Related]
11. Type I reaction in a borderline leprosy case successfully treated with multidrug therapy and ofloxacin.
Asz-Sigall D; López-García L; Neme-Yunes Y; Yuen-Palos R; Vega-Memije ME; Arenas R
Int J Dermatol; 2008 Oct; 47(10):1084-6. PubMed ID: 18986365
[No Abstract] [Full Text] [Related]
12. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
Suneetha S; Reddy R
Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):53-4. PubMed ID: 11480321
[No Abstract] [Full Text] [Related]
13. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations].
Sansarricq H
Acta Leprol; 1986; 4(3):355-62. PubMed ID: 3551474
[No Abstract] [Full Text] [Related]
14. Leprosy: not always an easy diagnosis and often a management challenge.
Manifold R; Marshman G
Australas J Dermatol; 2009 Feb; 50(1):36-40. PubMed ID: 19178490
[TBL] [Abstract][Full Text] [Related]
15. [What is your diagnosis? Sensory motor polyneuropathy in borderline leprosy. Trophic skin disorders with ulcerations, local superinfection on the right foot with right inguinal lymphadenopathy].
Siccoli M; Bassetti C
Praxis (Bern 1994); 2002 Jan; 91(3):49-52. PubMed ID: 11845612
[No Abstract] [Full Text] [Related]
16. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
Young RJ; Gilson RT; Elston DM
Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
[TBL] [Abstract][Full Text] [Related]
17. [New WHO recommendations for the treatment of leprosy].
Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
[No Abstract] [Full Text] [Related]
18. Multibacillary Mid-Borderline Leprosy with Type 1 Lepra Reaction and Concurrent Latent Tuberculosis.
Chew R; Woods ML
Am J Trop Med Hyg; 2021 Oct; 106(2):373-375. PubMed ID: 34695791
[No Abstract] [Full Text] [Related]
19. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
20. Serological monitoring of the response to chemotherapy in leprosy patients.
Roche PW; Britton WJ; Failbus SS; Neupane KD; Theuvenet WJ
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):35-43. PubMed ID: 8326179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
